Diffuse alveolar hemorrhage in a patient with anti-neutrophil cytoplasm antibody-associated vasculitis successfully treated with immunoadsorption combined with methylprednisolone

Jin, Shanshan; Wang, Danqiong; Luo, Jian; Zhang, Weiwen; Wu, Meng.
Med. clín (Ed. impr.) ; 158(3): 133-136, febrero 2022.
Artículo en Inglés | IBECS (España) | ID: ibc-204093

Documentos relacionados

  1. Diffuse alveolar hemorrhage in a patient with anti-neutrophil cytoplasm antibody-associated vasculitis successfully treated with immunoadsorption combined with methylprednisolone.
  2. Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS).
  3. Clinical features and outcomes of small airway disease in ANCA-associated vasculitis.
  4. [Pulmonary manifestations of anti-neutrophil cytoplasmic antibody associated vasculitis].
  5. Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation.
  6. Early infectious risk in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis according to remission-induction therapy.
  7. Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.
  8. Cardiovascular Disease in Anti-neutrophil Cytoplasm Antibody-Associated Vasculitis.
  9. Renal and overall outcomes of double-positive (ANCA and anti-GBM antibodies) patients compared to ANCA-associated vasculitis patients with severe renal involvement: A multicenter retrospective study with systematic renal pathology analysis.
  10. Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides?